Timothy Morris | CFO |
Maria Fardis | President & CEO |
Debora Barton | SVP, Clinical Science |
Mark Breidenbach | Oppenheimer |
Boris Peaker | Cohen |
George Zavoico | B. Riley FBR |
Good afternoon, and welcome to the Iovance Biotherapeutics Fourth Quarter and Year End 2018 Financial Results Conference Call. All participants are in a listen-only mode.
Following the formal remarks, we will open the call up for your questions. Please be advised that the call is being recorded at the company's request.
Now I would like to turn the conference over to Tim Morris, Chief Financial Officer at Iovance.